临床外科杂志 ›› 2024, Vol. 32 ›› Issue (5): 484-488.doi: 10.3969/j.issn.1005-6483.2024.05.012

• 论著 • 上一篇    下一篇

胃癌术后辅助化疗期间恶心呕吐风险预测模型的建立及验证

  

  1. 410007   长沙,湖南中医药大学第一附属医院神经内科(张慧),血液肿瘤科(张萍),胃肠外科(郭汝),教育教学与研究生工作部(何娅娜)
  • 收稿日期:2024-01-03 修回日期:2024-01-03 接受日期:2024-01-03 出版日期:2024-05-25 发布日期:2024-05-25
  • 通讯作者: 何娅娜,Email:909932870@qq.com
  • 基金资助:
    湖南省中医药科研计划项目(HN-LL-KY-2023-005-01)

Establishment and validation of a risk prediction model for nausea and vomiting during postoperative chemotherapy in gastric cancer patients

  1. Department of Neurology,The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410007,China
  • Received:2024-01-03 Revised:2024-01-03 Accepted:2024-01-03 Online:2024-05-25 Published:2024-05-25

摘要: 目的 探讨胃癌病人手术后化疗期间恶心呕吐的风险因素,并构建相应的风险预测模型。方法  2020年2月~2021年2月收治的胃癌病人作为建模集组,用于探讨胃癌病人手术后化疗期间恶心呕吐的风险因素,并构建相应的风险预测模型,将2021年3月~2022年2月(第1年)、2022年3月~2023年2月(第2年)、2023年3月~2024年2月(第3年)作为验证集组用于验证建模集组构建的风险预测模型。统计建模集组病人化疗期间呕吐发生情况。采用单因素和多因素 Logistic 回归分析胃癌病人手术后化疗期间恶心呕吐风险因素,并构建相应的风险预测模型。采用受试者工作特征曲线(receiver operating characteristic curve,ROC)以2021年3月~2024年2月3年的验证集验证列线图预测模型的准确性。结果  建模集组共纳入112例,其中75例未发生化疗相关性恶心呕吐,纳入对照组,37例病人发生了化疗相关性恶心呕吐,纳入观察组。单因素分析显示,年龄、性别、饮酒史、晕动病史、化疗次数、既往化疗相关性恶心呕吐史、妊吐史、匹茨堡睡眠质量指数(PSQI)、心理预期发生化疗后恶心呕吐等与病人发生化疗相关性恶心呕吐有关(P<0.05)。将单因素分析得到具有统计学意义的因素进行Logistic回归分析,结果显示,年龄、性别、晕动病史、化疗次数、妊吐史、PSQI、心理预期发生化疗后恶心呕吐是胃癌病人术后化疗期间恶心呕吐的危险因素(P<0.05)。根据Logistic回归得到具有统计学意义的因素构建风险预测模型。使用Bootstrap法对模型进行内部验证,第1年验证集组ROC曲线下面积(AUC) 为0.71(95%CI:0.71~1.00),第2年验证集组0.69(95%CI:0.58~0.96),第3年验证集组0.66(95%CI:0.54~0.95)。结论 年龄、性别、晕动病史、化疗次数、妊吐史、PSQI、心理预期发生化疗后恶心呕吐是胃癌病人术后化疗期间恶心呕吐的危险因素,上述因素构建的胃癌病人化疗期间恶心呕吐的风险预测模型具有较好的预测效能。

关键词: 胃癌, 化疗, 恶心呕吐, 风险预测模型

Abstract: Objective To investigate the risk factors of nausea and vomiting during postoperative chemotherapy in patients with gastric cancer and to construct a corresponding risk prediction model.Methods This study collected gastric cancer patients from the first affiliated hospital of Hunan university of traditional Chinese medicine from February 2020 to February 2021 as a modeling set to explore the risk factors of nausea and vomiting during chemotherapy in gastric cancer patients after surgery,and constructed a corresponding risk prediction models.The data were collected from March 2021 to February 2022(Year 1),March 2022 to February 2023(Year 2),and March 2023 to February 2024(Year 3) as a validation set,which was used to validate the risk prediction model constructed by the modeling set.The incidence of vomiting during chemotherapy was detected in the modeling set.The univariate and multivariate Logistic regression to analyze the risk factors of nausea and vomiting during chemotherapy in gastric cancer patients after surgery,and constructing a corresponding risk prediction model.The accuracy of the corresponding risk prediction model was validated using receiver operating characteristic curve(ROC) with a validation set from March 2021 to February 2024.Results  A total of 112 patients were included in the modeling set,of which 75 patients(66.96%) did not have nausea and vomiting during postoperative chemotherapy and were included in the control group,while 37 patients(33.04%) developed nausea and vomiting during postoperative chemotherapy and were included in the observation group.The univariate analysis showed that age,gender,history of alcohol consumption,history of motion sickness,frequency of chemotherapy,history of chemotherapy-related nausea and vomiting,history of vomiting during pregnancy,Pittsburgh sleep quality index(PSQI) and psychological expectation of post chemotherapy nausea and vomiting were related to the occurrence of nausea and vomiting during postoperative chemotherapy(P<0.05).Logistic regression analysis showed that age,gender,history of motion sickness,chemotherapy frequency,history of vomiting during pregnancy,PSQI,and psychological expectation of postoperative nausea and vomiting in gastric cancer patients were risk factors for nausea and vomiting during postoperative chemotherapy(P<0.05).A risk prediction model based on Logistic regression to identify statistically significant factors.Internal validation of the model was conducted by the Bootstrap method,with an area under curve(AUC) of 0.71(95% CI:0.71-1.00) for the first year validation set,0.69(95% CI:0.58-0.96) for the second year validation set,and 0.66(95% CI:0.54-0.95) for the third year validation set.Conclusion The Age,gender,history of motion sickness,frequency of chemotherapy,history of vomiting during pregnancy,PSQI and psychological expectation of postoperative nausea and vomiting during chemotherapy are risk factors for nausea and vomiting during postoperative chemotherapy.The risk prediction model for nausea and vomiting during chemotherapy in gastric cancer patients constructed based on the above factors has good predictive performance and can provide reference for clinical treatment of gastric cancer patients.

Key words: gastric cancer, chemotherapy, nausea, vomiting, risk prediction model

[1] 谢华辉 沈明 张仁浩 牛天峰 罗靖 李明堃 何文涛 熊健. 肝粘贴悬吊法、W型悬吊肝左叶、前腹壁肝脏V型悬吊法在腹腔镜胃癌根治术中的应用[J]. 临床外科杂志, 2024, 32(4): 406-410.
[2] 王惠君 乔莉娜 金鲜珍. 血清外泌体hsa_circ_0008035在胃癌前病变和早期胃癌中的临床意义[J]. 临床外科杂志, 2024, 32(4): 411-416.
[3] 林勇 赵占学. 叉头框蛋白M1和程序性细胞死亡受体1配体在胃癌组织中的表达及其与临床预后的相关性研究[J]. 临床外科杂志, 2024, 32(4): 417-420.
[4] 沈辉 云天奇 代伟宏. 急危重多发伤胃肠破裂急诊修复术后不良预后风险预测模型的构建与验证[J]. 临床外科杂志, 2024, 32(4): 425-428.
[5] 许代园 郗磊 姜祯珍 陈媛媛 王佩. 七氟烷调控miR-96-5p/SIK1轴对胃癌细胞恶性生物学行为的影响[J]. 临床外科杂志, 2024, 32(4): 433-437.
[6] 熊坚威 李强 唐涛 张立鑫 英保 赵开烽 熊永福 李敬东 武国. 经肝动脉化疗栓塞联合酪氨酸激酶抑制剂及程序性死亡受体-1抗体治疗中晚期不可切除肝细胞癌的临床疗效和安全性分析[J]. 临床外科杂志, 2024, 32(2): 176-181.
[7] 王少怡 聂凯 李冉冉 陈达丰 薛小军 叶磊 刘建平 周松. XELOX方案新辅助化疗治疗Ⅱ(T4)期、Ⅲ期结肠癌的疗效分析[J]. 临床外科杂志, 2024, 32(2): 188-191.
[8] 江涛 张伟 邱晓光 王政 张忠 陈宝师 刘彦伟 刘帅. 2023欧洲神经肿瘤协会原发性中枢神经系统淋巴瘤治疗指南解读[J]. 临床外科杂志, 2024, 32(1): 10-13.
[9] 杜雨强 蒋祈 张鹏 陶凯雄. 美国国立综合癌症网络临床实践指南:胃癌(2023.V2)更新解读[J]. 临床外科杂志, 2024, 32(1): 31-33.
[10] 龙凯军 陈旺文 罗之谦. 胃癌病人术后发生静脉血栓栓塞症危险因素分析以及预测模型的建立[J]. 临床外科杂志, 2024, 32(1): 84-88.
[11] 刘峻峰 金方童 刘晓平. 同时性早期胃癌合并肺癌一例[J]. 临床外科杂志, 2024, 32(1): 111-112.
[12] 王青峰 陆晶晶 鲁生林 汪源 吴永丰 张明府. 新辅助化疗后行腹腔镜胃癌根治术并发症有关影响因素及预后分析[J]. 临床外科杂志, 2023, 31(9): 860-863.
[13] 李一博 宋炎阳. 胃癌腹腔镜胃远端切除术不同吻合方式对并发症及胃肠功能的影响[J]. 临床外科杂志, 2023, 31(9): 865-868.
[14] 张明燃 范玥 李俊. 胃癌根治性切除消化道重建术后Petersen疝11例临床分析[J]. 临床外科杂志, 2023, 31(9): 877-880.
[15] 马立东 刘晓蕾 赵飞. 青蒿素通过TLR4/NF-κB信号通路调节胃癌细胞的生长和炎症因子分泌的机制研究[J]. 临床外科杂志, 2023, 31(8): 738-741.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[2] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[3] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[4] 宋华;单若冰;张晋绥;等. 产前超声诊断对新生儿消化道梗阻性疾病手术治疗价值的观察[J]. 临床外科杂志, 2016, 24(10): 780 .
[5] 陈凛;崔建新. 胃癌术后复发与再手术[J]. 临床外科杂志, 2016, 24(11): 813 .
[6] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[7] 刘江豪;李刚;张克强;等. 机器人辅助甲状腺切除术和腔镜甲状腺切除术治疗cN0期分化型甲状腺癌的有效性、安全性Meta分析[J]. 临床外科杂志, 2016, 24(11): 852 .
[8] 刘鑫;金慧芳;张硕;等. 尿激酶治疗结核性包裹性胸腔积液不同时间后手术治疗的疗效分析[J]. 临床外科杂志, 2016, 24(11): 859 .
[9] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[10] 凌地洋;王哲银;卢振和;等. 自体血注射联合吲哚美辛巴布膏治疗顽固性网球肘的临床疗效观察[J]. 临床外科杂志, 2016, 24(11): 882 .